Functional Assessment of Myocardial Ischemia by Intracoronary Electrocardiogram
FFRicECG
1 other identifier
interventional
100
1 country
1
Brief Summary
In patients with chronic stable coronary artery disease (CAD), percutaneous coronary intervention (PCI) targets hemodynamically significant coronary lesions, i.e., those thought to cause inducible ischemia. The hemodynamic severity of a coronary stenosis increases with its tightness and with the myocardial mass of viable myocardium downstream of the stenosis. Compared to the traditional anatomic angiographic approach, assessment of functional relevance by fractional flow reserve (FFR) during coronary angiography has been suggested to improve patient outcomes. Fractional flow reserve (FFR) is based on determination of the coronary perfusion pressure downstream of a stenosis during pharmacologic hyperemia. However, FFR relies on oversimplified physiologic concepts, which limits its usefulness in defining a true ischemic threshold. Furthermore, visual angiographic assessment continues to dominate the treatment decisions for intermediate coronary lesions. Conversely, the intracoronary ECG (icECG) provides an inexpensive, sensitive and direct measure of myocardial ischemia. The icECG is easily acquired by attaching a reusable alligator clamp to a conventional angioplasty guidewire (at one tenth the price of a pressure sensor guidewire). The coronary guide wire positioned downstream of a coronary stenosis then acts as the exploring electrode. During pharmacologic stress, the icECG can provide direct evidence for regional myocardial ischemia to define the ischemic threshold in different types of coronary artery disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable coronary-artery-disease
Started Dec 2016
Typical duration for not_applicable coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 3, 2016
CompletedFirst Submitted
Initial submission to the registry
June 5, 2019
CompletedFirst Posted
Study publicly available on registry
June 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 13, 2019
CompletedDecember 19, 2019
December 1, 2019
3 years
June 5, 2019
December 18, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intracoronary Electrocardiogram ST-Segment Shift
Change in intracoronary ST-segment shift from baseline to hyperemia, measured at the J-Point in mV
Measured at maximal heart frequency (=~6min after begin dobutamine)
Secondary Outcomes (4)
Percent Diameter Stenosis
During diagnostic angiography at the beginning of the coronary angiography
Fractional Flow Reserve
Measured at maximal heart frequency (=~6min after begin dobutamine)
Instantaneous wave-free ratio
Measured at baseline before inotropic stress
Area at Risk
Measured after the coronary angiography, expected to be on average after 3 days
Study Arms (1)
Functional Assessment of Myocardial Ischemia by icECG
EXPERIMENTALEvaluation of ST-Shifts in the icECG acquired downstream of a coronary lesion during pharmacologic inotropic stress using dobutamine (40mcg/kg/min).
Interventions
Eligibility Criteria
You may qualify if:
- Age \> 18 years
- Referred for elective coronary angiography
- Written informed consent to participate in the study
You may not qualify if:
- Acute coronary syndrome
- Severe aortic stenosis
- Acute congestive heart failure NYHA III-IV
- Prior myocardial infarction in the vascular territory undergoing pressure measurements
- Presence of left bundle branch block, non-sinus rhythm or paced rhythm in resting ECG
- Coronary anatomy unsuitable for coronary pressure measurements
- Severe pulmonary, renal or hepatic disease
- Contraindication to inotropic stress
- Women of childbearing age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Inselspital, Bern
Bern, Switzerland
Related Links
- Friedman et al. Circulation 1986 - Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty.
- de Marchi et al. JACC 2012 - Determinants of prognostically relevant intracoronary electrocardiogram ST-segment shift during coronary balloon occlusion.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian Seiler, MD, Prof
Inselspital, Bern University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2019
First Posted
June 13, 2019
Study Start
December 3, 2016
Primary Completion
December 13, 2019
Study Completion
December 13, 2019
Last Updated
December 19, 2019
Record last verified: 2019-12